Back to Search
Start Over
Papulopustular rosacea during nivolumab therapy of metastatic squamous cell esophageal carcinoma.
- Source :
- Dermatology Online Journal; 2021, Vol. 27 Issue 9, p1-4, 4p
- Publication Year :
- 2021
-
Abstract
- We present a 76-year-old man who developed papulopustular rosacea after receiving nivolumab treatment for his esophageal carcinoma, metastatic to the lungs. Nivolumab is an emerging cancer therapy whose immune-related adverse events are still not fully recognized and likely underreported. The treatment has been reported to cause a myriad of cutaneous immune-related adverse events. However, nivolumab-induced-papulopustular rosacea has been scarcely reported. Thus, this case presents a clinically important finding that physicians should be aware of when seeing patients on nivolumab therapy. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10872108
- Volume :
- 27
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Dermatology Online Journal
- Publication Type :
- Academic Journal
- Accession number :
- 153306170
- Full Text :
- https://doi.org/10.5070/D327955140